ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ALDX Aldeyra Therapeutics Inc

4,16
-0,05 (-1,19%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:06:41
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Aldeyra Therapeutics Inc ALDX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,05 -1,19% 4,16 22:06:41
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,23 4,075 4,29 4,16 4,21
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.4.202413:00BWAldeyra Therapeutics Highlights Recent Preclinical Data in..
18.4.202413:00BWAldeyra Therapeutics to Host Research & Development Day on..
28.3.202412:00BWAldeyra Therapeutics Announces Clinical Development Plan for..
07.3.202422:54EDGAR2Form S-3 - Registration statement under Securities Act of..
07.3.202422:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
07.3.202422:40EDGAR2Form S-8 POS - Securities to be offered to employees in..
07.3.202422:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06.2.202413:00BWAldeyra Therapeutics to Participate in the Oppenheimer 34th..
29.1.202423:25EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04.1.202413:00EDGAR2Form 8-K - Current report
04.1.202413:00BWAldeyra Therapeutics Provides Clinical and Regulatory Update..
21.12.202322:06EDGAR2Form 8-K - Current report
19.12.202313:05EDGAR2Form 8-K - Current report
19.12.202313:00BWAldeyra Therapeutics Announces Statistically and Clinically..
18.12.202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
28.11.202313:16EDGAR2Form 8-K - Current report
27.11.202322:07BWAldeyra Therapeutics Receives Complete Response Letter from..
03.11.202321:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
03.11.202321:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.11.202312:09EDGAR2Form 8-K - Current report
01.11.202312:05BWAldeyra Therapeutics Enters into Exclusive Option Agreement..
16.10.202314:00EDGAR2Form 8-K - Current report
27.9.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26.9.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19.9.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12.9.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11.9.202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.8.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
24.8.202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.8.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
16.8.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11.8.202311:45PRNUSALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
09.8.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
04.8.202311:45PRNUSALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
03.8.202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.7.202313:00BWAldeyra Therapeutics to Participate in SVB Securities..
05.7.202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.7.202322:07EDGAR2Form 8-K - Current report
29.6.202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.6.202313:01EDGAR2Form 8-K - Current report
29.6.202313:00BWAldeyra Therapeutics Announces Improvement from Baseline in..
28.6.202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
27.6.202313:00BWAldeyra Therapeutics Announces Statistically Significant..
26.6.202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
23.6.202313:00BWAldeyra Therapeutics to Join the Russell 2000® and Russell..
21.6.202315:34BWAldeyra Therapeutics Provides Regulatory Update on ADX-2191
15.6.202313:00BWAldeyra Therapeutics Announces Achievement of Statistical..
14.6.202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock